Hepatocellular carcinoma surveillance rates in commercially insured patients with noncirrhotic chronic hepatitis B

Publisher： John Wiley & Sons Inc

E-ISSN： 1365-2893|22|9|727-736

ISSN： 1352-0504

Source： JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol.22, Iss.9, 2015-09, pp. : 727-736

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Risk factors of hepatocellular carcinoma development in non‐cirrhotic patients with sustained virologic response for chronic hepatitis C virus infection

By  

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. 7, 2015-07 ,pp. : 1183-1189

John Wiley & Sons Inc

Access to resources Recommend Favorite

Prevention of Hepatocellular Carcinoma in Patients with Chronic Hepatitis B Virus Infection

By  

Oncology, Vol. 81, Iss. 1, 2011-12 ,pp. : 41-49

Karger

Access to resources Recommend Favorite

Effect of the Dose and Duration of Interferon-Alpha Therapy on the Incidence of Hepatocellular Carcinoma in Noncirrhotic Patients with a Nonsustained Response to Interferon for Chronic Hepatitis C

By  

Oncology, Vol. 61, Iss. 2, 2001-08 ,pp. : 134-142

Karger

Access to resources Recommend Favorite

Risk scores for hepatocellular carcinoma in chronic hepatitis B

By  

HEPATOLOGY, Vol. 61, Iss. 6, 2015-06 ,pp. : 1784-1786

John Wiley & Sons Inc

Access to resources Recommend Favorite

P060: Incidence of hepatocellular carcinoma in chronic hepatitis B patients responders to nucleoside analogue treatment

By  

JOURNAL OF VIRAL HEPATITIS (ELECTRONIC), Vol. 22, Iss. S2, 2015-06 ,pp. : 49-50

John Wiley & Sons Inc

Access to resources Recommend Favorite